Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
0.987
-0.033 (-3.25%)
At close: Dec 5, 2025, 4:00 PM EST
0.995
+0.008 (0.80%)
After-hours: Dec 5, 2025, 5:18 PM EST
Rockwell Medical Market Cap
Rockwell Medical has a market cap or net worth of $38.89 million as of December 5, 2025. Its market cap has decreased by -51.69% in one year.
Market Cap
38.89M
Enterprise Value
28.31M
1-Year Change
-51.69%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since December 1, 1998, Rockwell Medical's market cap has increased from $7.80M to $38.89M, an increase of 398.58%. That is a compound annual growth rate of 6.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 38.90M | -40.97% |
| Dec 31, 2024 | 65.90M | 22.49% |
| Dec 29, 2023 | 53.80M | 355.93% |
| Dec 30, 2022 | 11.80M | -69.35% |
| Dec 31, 2021 | 38.50M | -59.26% |
| Dec 31, 2020 | 94.50M | -39.46% |
| Dec 31, 2019 | 156.10M | 21.20% |
| Dec 31, 2018 | 128.80M | -57.24% |
| Dec 29, 2017 | 301.20M | -10.76% |
| Dec 30, 2016 | 337.50M | -35.47% |
| Dec 31, 2015 | 523.00M | 16.69% |
| Dec 31, 2014 | 448.20M | 7.33% |
| Dec 31, 2013 | 417.60M | 143.50% |
| Dec 31, 2012 | 171.50M | 8.48% |
| Dec 30, 2011 | 158.10M | 14.57% |
| Dec 31, 2010 | 138.00M | 5.18% |
| Dec 31, 2009 | 131.20M | 126.21% |
| Dec 31, 2008 | 58.00M | -30.54% |
| Dec 31, 2007 | 83.50M | 2.08% |
| Dec 29, 2006 | 81.80M | 108.14% |
| Dec 30, 2005 | 39.30M | 46.10% |
| Dec 31, 2004 | 26.90M | -20.88% |
| Dec 31, 2003 | 34.00M | 608.33% |
| Dec 31, 2002 | 4.80M | -47.25% |
| Dec 31, 2001 | 9.10M | 152.78% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |